We recently released a list 10 shares of billionaire Lei Zhang have huge upward potential. In this article, we will look at the stock picks of Danaher Corporation (NYSE:DHR) with other billionaire Lei Zhang has huge upward potential.
Lei Zhang, Founder and CEO Hillhouse Capitalis one of the most influential but low-key people in the investment world. Born and raised in China, Zhang later studied in the United States and received an MBA from Yale University, where he was influenced by David Swensen, the university’s legendary donation manager. It was with Swensen's support that Zhang launched Hillhouse in 2005, initially backed by capital from the Yale Endowment Fund. Hillhouse started to have smaller capital, but soon became a powerful country in Asia's rapid market development. The company is known for its long-term, research-driven approach, often holds important roles in high-growth companies and works with management teams to help expand their business. Zhang’s strategy is not to pursue short-term gains, but to focus on building a lasting competitive business.
One of Hillhouse's early and most famous investments was Chinese tech giant Tencent. The company joined and the bet paid off with great returns when the company remained relatively unknown outside of China. Other major holdings include JD, Baidu and Meituan, as well as a growing number of companies in areas such as healthcare, logistics and consumer goods. Zhang's investment style combines the elements of private equity and public market investment. He was not afraid of holding shares for many years, and Hillhouse often worked closely with portfolio companies to improve operations and governance. This hands-on collaboration model has helped the company build a strong reputation among entrepreneurs and institutional investors.
Hillhouse Capital has since expanded outside of China, now managing billions of dollars in Asia and other markets, with offices in Singapore, Hong Kong and New York. Despite its size, the company remains relatively cautious. Zhang himself rarely conducts interviews and avoids spotlights, rather letting the result talk to himself. Hillhouse investment has earned a reputation for outstanding returns, with a 52% establishment rate from its inception to 2012. Its expansion has achieved stable capabilities and can achieve strong results even if the company grows. Hillhouse has a wide range of departmental priorities, including technology and enterprise software. The company also often works with other major investors, such as Sequoia Capital, through co-investment partnerships.
Under Zhang's leadership, Hillhouse has become synonymous with the disciplined development of some of the world's most dynamic economies. For many, Zhang represents a new variety of global investors: a bridge between the East and the West and a long game in an increasingly complex financial field.
For this list, we selected stocks from Hillhouse Capital’s 13F portfolio as of the end of the fourth quarter of 2024. We list them in order of rising order of analyst average upward potential. These stocks are also popular among other hedge funds.
Note: All data were recorded on May 7, 2025.
At Insider Monkey, we are addicted to hedging stocks that have accumulated money. The reason is simple: Our research shows that we can beat the market by mimicking the top stocks of the best hedge funds. Our strategy for quarterly newsletters selects 14 small and large stocks every quarter, returning 373.4% since May 2014, beating its benchmark by 218 percentage points (See more details here).
A healthcare professional in a lab coat wearing a microscope looking at the slide under the camera.
Shares of Hillhouse Capital: $3,002,284
Upward potential: 26.77%
Number of hedge fund holders: 101
Danaher Corporation (NYSE:DHR) is a global science and technology company dedicated to improving human health through its more than 15 biotechnology, life sciences and diagnostic technologies. Operating in over 50 countries, Danaher emphasizes frequent revenue, direct sales models and Danaher business systems. Its strategy focuses on competitive forces, intelligent capital allocation and talent retention. Growth is driven by innovation, acquisitions and portfolio optimization, and its performance is measured by financial and non-financial metrics.
Danaher Corporation (NYSE:DHR)'s performance in Q2 2025 was highlighted, driven by Cepheid's strong demand for bioprocessing and elevated respiratory diagnosis. The total revenue was US$5.7 billion, which was flat year-on-year. The company highlights global uncertainty, revenue strength, product innovation and resilience in global revenue calls. Danaher reiterated guidance for 2025, with core revenue growing by 3% with adjusted EPS of $7.60-7.75, leveraging its Danaher business system and strong financial position to address challenges and invest in long-term growth.
Danaher reported strong bioprocessing performance, driven by growth in consumables and improved equipment demand, leading to an improved outlook for 2025. They expect high numbers to grow and are supported by strong orders and more than one book. The tariff impact is estimated at $350 million, offset by pricing actions, manufacturing transfers and cost savings. Due to the weaknesses of the US academic and government, life science guidance has decreased despite China's stability outside of VBP pressure.
Overall, DHR Ranked seventh There is huge upside potential in the stock picks of our billionaire Lei Zhang. While we acknowledge the potential of DHR as an investment, our belief is that AI stocks have huge returns in a shorter time frame and do this in a shorter time frame. AI stocks have risen since the beginning of 2025, while popular AI stocks have lost about 25%. If you are looking for AI stocks that are more promising than DHR but have less than 5 times its earnings, check out our report Cheapest AI stocks.
Read the next article: Buy 20 Best AI Stocks Now and According to the billionaire, there are now 30 best stocks.
Disclosure: None. This article was originally published in Internal monkey.